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Background: The COVID-19 pandemic has put several healthcare systems under severe pressure. The present
analysis investigates how the first wave of the COVID-19 pandemic affected the myocardial infarction (MI)
network of Emilia-Romagna (Italy).
Methods: Based on Emilia-Romagna mortality registry and administrative data from all the hospitals from
January 2017 to June 2020, we analysed: i) temporal trend in MI hospital admissions; ii) characteristics, man-
agement, and 30-day mortality of MI patients; iii) out-of-hospital mortality for cardiac cause.
Findings: Admissions for MI declined on February 22, 2020 (IRR -19.5%, 95%CI from -8.4% to -29.3%, p = 0.001),
and further on March 5, 2020 (IRR -21.6%, 95%CI from -9.0% to -32.5%, p = 0.001). The return to pre-COVID-19
MI-related admission levels was observed from May 13, 2020 (IRR 34.3%, 95%CI 20.0%-50.2%, p<0.001). As
compared to those before the pandemic, MI patients admitted during and after the first wave were younger
and with fewer risk factors. The 30-day mortality remained in line with that expected based on previous
years (ratio observed/expected was 0.96, 95%CI 0.841.08). MI patients positive for SARS-CoV-2 were few
(1.5%) but showed poor prognosis (around 5-fold increase in 30-day mortality). In 2020, the number of out-
of-hospital cardiac deaths was significantly higher (ratio observed/expected 1.17, 95%CI 1.081.27). The
peak was reached in April.
Interpretation: In Emilia-Romagna, MI hospitalizations significantly decreased during the first wave of the
COVID-19 pandemic. Management and outcomes of hospitalized MI patients remained unchanged, except for
those with SARS-CoV-2 infection. A concomitant increase in the out-of-hospital cardiac mortality was observed.
Funding: None.
© 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/)zienda Ospedaliero-Universi-
Italy.
Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
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Evidence before this study
Since the COVID-19 pandemic started to spread globally, sev-
eral studies have been carried out to understand it and investi-
gate its effect on society. Some of the works focusing on
myocardial infarction (MI) have reported a significant reduction
in daily hospital admissions for MI. Others showed an increase
in out-of-hospital cardiac arrests. Less information is available
about the management and mortality of MI patients throughout
COVID-19 pandemic, and it is still unclear if the reduction in
daily admissions for MI is linked to the increased out-of-hospi-
tal cardiac deaths.
Added value of this study
The present analysis is based on the data of the Emilia-Roma-
gna region, one of the most severely hit areas of Italy. Our team
had access to all the citizens' clinical data and hospitals' data-
base of the region, including in- and out-of-hospital mortality.
The data showed a reduction in admissions for MI from Febru-
ary 22 to May 13, 2020. However, during that period, patients
with MI who were admitted to hospital were treated with the
same gold standards as before the pandemic, which meant no
significant variation in the 30-day mortality rates. The number
of MI patients positive for SARS-CoV-2 infection was not signifi-
cantly high (1.5% of the cases), but their prognosis was worse,
with 30-day mortality exceeding 30%. In 2020, the number of
out-of-hospital cardiac deaths was significantly increased,
peaking in March and April 2020.
Implications of the available evidence
Our research confirmed that a well-organized MI network can
offer gold-standard treatments even during a devastating pan-
demic, resulting in a not significant variation in 30-day mortal-
ity. On a less positive note, we observed a substantial increase
in out-of-hospital cardiac deaths, together with the reduction
in hospital admissions for MI. These data should reinforce the
need for social, media, and political campaigns to reassure the
population regarding the safety and efficacy of well-organized
emergency networks even during a pandemic.1. Introduction
Emilia-Romagna is a North of Italy region with around 4.5 million
inhabitants, more than 50 hospitals and a well-structured public
emergency service [1-3]. The network for the myocardial infarction
(MI), involving more than 50 emergency rooms, 17 spoke cardiology
units and 10 hub centres with 24/7 cardiac catheterization services,
is one of the flagships of the regional health service [1-4]. The COVID-
19 pandemic has had a profound effect on the regional health system,
inducing changes in organization and assistance to face more than
100,000 cases and 4400 deaths during the first wave. Worldwide, it
has been reported that the COVID-19 outbreak has had an enormous
impact on MI management [5-12]. Delayed hospital presentations
have become common [5]. Some networks had to introduce unex-
pected changes in pathways and treatments (i.e., pharmacological
instead of mechanical coronary reperfusion) [6,7]. In addition, several
studies highlighted a significant decline in the number of hospital
admissions for MI, and the national lockdowns imposed by authori-
ties have been advocated as potential causes [8-12].The current investigation has been carried out to describe the per-
formance of the Emilia-Romagna MI network and the whole spec-
trum of the consequences on it due to COVID-19 pandemic. For this
purpose, from January 2017 to June 2020, the trend and the changes
in hospital admission for MI, the 30-day mortality of MI patients
(with or without concomitant COVID-19), as well as the out-of-hospi-
tal mortality for cardiac cause, were analysed and compared.
2. Methods
2.1. Data collection
The AMI-Co (Acute Myocardial Infarction during Coronavirus dis-
ease 2019) is a population-based, observational study. The identifica-
tion of patients admitted to hospital for MI is based on administrative
data generated at hospital discharge from all hospitals of the Emilia-
Romagna (Italy) (supplemental online). Since 1999, discharge hospi-
tal records were tracked in a single electronic database. The records
contain detailed information concerning patient details, hospitaliza-
tion, primary and secondary diagnoses, and diagnostic/therapeutic
procedures performed. MI diagnosis, as well as the diagnostic and
therapeutic procedures, were defined according to the International
Classification of Diseases, 9th Revision (ICD-9). A detailed list of
methods and ICD-9 codes is available in the supplemental appendix
(Supplemental Table 1). The data extraction was in line with a vali-
dated protocol periodically applied for national (https://pne.agenas.
it/), and regional (https://assr.regione.emilia-romagna.it) audits of
the healthcare system. Mortality rates of patients admitted to hospi-
tal for MI were obtained by analysis of hospital discharge records and
mortality registry (supplemental online). Similarly, mortality registry
was used to identify subjects who died out-of-hospital for cardiac
cause (supplemental online). The identification of all subjects positive
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection was performed by the interrogation of the dedicated
regional database. Access to this information has enabled us to cover
the entire resident population of the region and ensures a complete
follow-up and the identification of the cause of death (supplemental
online). The review boards approved the protocol (Comitato Etico di
Area Vasta Emilia Centro, approval id #3812020). Since the study
was based on data drawn from routine daily practice, no informed
consent was required.
2.2. Procedures and definitions
In addition to standard baseline characteristics (age, sex, resi-
dence, etc.) and comorbidities (arterial hypertension, hyperlipidae-
mia, diabetes mellitus, chronic kidney disease, chronic obstructive
pulmonary disease, prior cardiovascular events, etc.), the following
variables were collected: date of admission, clinical presentation (ST-
segment elevation MI or non-ST-segment elevation MI), use of pri-
mary percutaneous coronary intervention (PCI) in STEMI patients,
first medical contact to balloon time, use of invasive strategy in
NSTEMI patients, timing from admission to coronary angiography in
NSTEMI patients, SARS-CoV-2 infection. SARS-CoV-2 infection was
confirmed by CE-marked reverse-transcriptase-polymerase-chain-
reaction assay from nasopharyngeal swab specimen. The analysis
was performed in referral laboratories of the region.
The first objective of the present investigation was to describe the
temporal trends in the number of hospital admissions for MI. Accord-
ingly, all patients admitted for MI from January 2017 to June 2020
were identified. The second objective was to outline the characteris-
tics, management, and 30-day mortality of MI patients admitted in
the 2020 and compare this with the same information from
previous years (pre-COVID-19 normality, from January 2017 to
December 2019). MI patients admitted in the 2020 were divided in
three subgroups (the selection is based on trend of the pandemic in
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February 21 (before pandemic), from February 22 to May 13 (first
wave of the pandemic), from May 14 to June 30 (after the first wave
of the pandemic). The number, treatments, and outcomes of patients
admitted to hospital primarily for acute MI but also diagnosed posi-
tive for SARS-CoV-2 infection were reported separately. Finally, the
third objective was to describe variations in the occurrence of out-of-
hospital mortality for cardiac cause from January 2017 to June 2020.
The cause of death was retrieved from death certificates. Briefly, the
cases were identified in presence of one of the ICD-10 codes of myo-
cardial infarction. A detailed description of the methodology and
codes allowing the identification of cardiac death is available in the
supplemental online.2.3. Statistical analysis
A detailed description of the statistical methods is available in the
supplemental online. Briefly, continuous variables were reported as
mean§ standard deviation (SD) and compared using Student’s t-tests
or Mann-Whitney tests. Categorical variables were expressed as
number and percentage and compared using x2 tests. To describe the
trend of daily hospital admissions for MI and the impact of COVID-19
pandemic, a population-based interrupted time series design and
segmented regression analysis were carried out. After verifying the
absence of overdispersion, checking residual deviances, Poisson mod-
els were applied to estimate time series trends (general population
and subgroups). The models included time, weekly and annual sea-
sonality of MI hospitalizations as covariates. The residual autocorrela-
tion was checked through Ljung-Box test. Subsequently, an iterative
procedure was carried out to detect any significant disruptions in the
trend. The breakpoints identified were included as covariates in addi-
tional Poisson models, to assess the related incident rate ratio (IRR)
between hospitalizations observed and expected. Further Poisson
models were carried out to analyze, in different time range, the IRR
between MI hospital admissions observed in 2020 and those
expected, based on 20172019 data. To assess 30-day mortality, a
multivariable logistic regression, including the variables listed in
Table 1 as covariates, was performed. Data from the years
20172019 were entered in the multivariable logistic regression and
the model estimated were later applied to 2020 data to evaluate the
expected deaths, adding the probability estimated for each patient.
The ratio of number of deaths observed - to those expected (SMR)
was measured to estimate any excess mortality that occurred in the
time intervals of interest. The SMR 95%CI was calculated as 1.96 x
standard error of SMR and if the 95%CI did not cross the 1 value, the
SMR was considered statistically significant. Finally, to analyze out-
of-hospital cardiac deaths, age-sex-specific rates detected in the first
six months, from 2017 to 2020, were considered. The rates of out-of-
hospital cardiac death were calculated as the ratio between the num-
ber of deaths stratified by sex and age group of 5 years and the
amount of the resident population at the beginning of each year of
the same age group and sex. IRR between observed and expected
rates, stratified for temporal windows, was estimated through Pois-
son regression model with count of deaths, stratified by 5-year age
classes and sex, as dependent variable, log of the amount of resident
population, stratified by 5-year ag classes and sex, as offset and year
2020, expressed as dichotomous variable, 5-years age classes, sex
and age-sex interaction, as covariates. All analyses were performed
using R version 3.6.3 (The R Foundation for Statistical Computing,
Wien) and SAS version 9.3 (SAS Institute, Inc. Cary, NC, USA).2.4. Role of the funding source
There was no funding source for this study. The Executive Com-
mittee of the AMI-Co study (supplemental online) had full access toall the data and had final responsibility for the decision to submit for
publication.3. Results
From January 2017 to June 2020, 31,381 hospital admissions for
MI were calculated. Of note, 12,164 (38.7%) admissions were for
STEMI, whereas 19,217 (61.3%) for NSTEMI. The daily average num-
ber declined from 2017 to 2019, with the typical seasonal variability
(Fig. 1, supplemental Fig. 1). As compared to the expected trend, an
abrupt reduction in daily MI admissions was observed on February
22, 2020 (IRR 19.5%, 95%CI from 8.4% to 29.3%, p = 0.001) (Fig. 1).
A further significant reduction was observed on March 5, 2020 (IRR
21.6%, 95%CI from 9.0% to 32.5%, p = 0.001) (Fig. 1). A first inver-
sion in the tendency is observed on April 17, 2020 (IRR 23.4%, 95%CI
9.2%39.5%, p = 0.0008) (Fig. 1), with a further increase in admissions
from May 13, 2020 (IRR 34.3%, 95%CI 20.0%50.2%, p<0.001) (Fig. 1).
Repeating the analyses on the national lockdown window (from
March 9 to May 4) did not change the findings (IRR 31.9%, 95%CI
from 36.5% to 27.0%, p<0.001).
In 2020, 3728 patients were admitted to hospital for MI. Of note,
3672 (98.5%) of them were negative for SARS-CoV-2 infection
(Table 1), whereas 56 (1.5%) resulted positive for SARS-CoV-2 infec-
tion (Table 2). Looking at MI patients negative for SARS-CoV-2 infec-
tion, those hospitalized during and after the pandemic’s first wave
were younger and with fewer risk factors and prior cardiac events, as
compared to those admitted before pandemic (Table 1). Similar find-
ings were observed comparing the MI patients of the year 2020 with
those of the years 20172019 (temporal window February 22  May
12) (Supplemental Table 3). For what concerns the treatments, the
timing for invasive strategy was shorter in NSTEMI patients admitted
after the onset of the pandemic (Table 1). From 2017 to 2020, 30-day
mortality of MI patients remained unchanged, ranging around 8.5%
(Fig. 2). After correction for potential confounding factors (Supple-
mental Table 4), we did not find significant variations in the 30-day
mortality of the MI patients hospitalized and treated in 2020 (Fig. 2).
The number of observed deaths in 2020 was in line with that
expected on data of years 20172019 (ratio observed/expected 0.96,
95%CI 0.861.11) (Fig. 2, Supplemental Table 5). The ratio observed/
expected was constant before, during and after the first wave of the
pandemic, as well as during the national lockdown (Fig. 2).
Looking at MI patients who were confirmed positive for SARS-
Cov-2 infection (Table 2), we found that, as compared to others, they
were older and with more history of heart failure (Table 2). In addi-
tion, they were under-treated and with a longer hospital stay
(15.2 § 14.3 vs. 7.2 § 6.9, respectively) (Table 2). At follow-up, 18
(32%) of them died, being SARS-CoV-2 infection an independent pre-
dictor of 30-day mortality (OR 5.1, 95%CI 2.98.8, p<0.001) (Supple-
mental Table 6). Respiratory failure, cardiogenic shock and bleeding
complications were the most common final events in these patients.
From January 2017 to June 2020, 4510 deaths for cardiac cause
were counted out-of-hospital (Supplemental Table 7). The daily num-
ber of out-of-hospital cardiac death throughout the years is shown in
Fig. 3. The mean age (80§12 years) and the percentage of male sex
(55.7%) in the subjects who died did not vary throughout the years
(Supplemental Fig. 2). The same pattern was observed for main car-
diovascular risk factors (Supplemental Fig. 2). An abrupt increase in
the number of out-of-hospital cardiac deaths was observed in 2020
(Fig. 3). After correction for age and sex and as compared to the
expected number based on 20172019 data, we confirmed the
increase in the number of out-of-hospital cardiac deaths in 2020
(ratio observed/expected 1.17, 95%CI 1.081.27) (Fig. 3, Supplemen-
tal Table 8). The excess of out-of-hospital cardiac deaths was concen-
trated from February to April 2020, with the peak in April 2020 (ratio
observed/expected 1.62, 95%CI 1.321.98) (Fig. 3). Repeating the
Table 1
Patient characteristics of MI patients negative for SARS-CoV-2 infection admitted in 2020.
Timing of hospitalization on 2020 though COVID-19 pandemic
Before First wave After p1 p2
(n = 1343) (n = 1301) (n = 1028)
Age, years 72.8 § 13 71.5 § 13 71.0 § 13 0.013 0.003
< 65 years, no. (%) 342 (25.5) 377 (29) 341 (33.2) 0.027 <0.01
6574 years, no. (%) 341 (25.4) 335 (25.7) 225 (21.9)
7584 years, no. (%) 394 (29.3) 384 (29.5) 290 (28.2)
85 years, no. (%) 266 (19.8) 205 (15.8) 172 (16.7)
Male sex, no. (%) 885 (65.9) 866 (66.6) 666 (64.8) 0.717 0.573
Comorbidities, no. (%)
Diabetes 298 (22.2) 299 (23) 215 (20.9) 0.626 0.455
Hypertension 804 (59.9) 542 (41.7) 354 (34.4) <0.001 <0.001
Hyperlipidaemia 839 (62.5) 604 (46.4) 409 (39.8) <0.001 <0.001
Prior MI 235 (17.5) 185 (14.2) 147 (14.3) 0.021 0.036
History of HF 295 (22) 248 (19.1) 176 (17.1) 0.065 0.003
Peripheral artery disease 67 (5) 52 (4) 44 (4.3) 0.219 0.418
Cerebrovascular disease 87 (6.5) 98 (7.5) 80 (7.8) 0.288 0.219
COPD 62 (4.6) 45 (3.5) 51 (5) 0.131 0.696
Chronic kidney disease 155 (11.5) 119 (9.1) 103 (10) 0.043 0.238
History of cancer 8 (0.6) 11 (0.8) 8 (0.8) 0.447 0.591
Charlson Index >2 214 (15.9) 206 (15.8) 161 (15.7) 0.944 0.857
Hospitalization
STEMI, no. (%) 529 (39.4) 521 (40.0) 395 (38.4) 0.73 0.633
Anterior location STEMI 259 (48.9) 266 (51.1) 197 (49.9) 0.478 0.762
Inferior location STEMI 230 (43.5) 217 (41.7) 170 (43.0) 0.549 0.894
Coronary angiography 496 (93.7) 490 (94.1) 372 (94.2) 0.762 0.651
Primary PCI 426 (80.5) 420 (80.7) 320 (81.0) 0.725 0.891
FMC-balloon time, minutes * 85§40 87§45 86§43 0.565 0.784
NSTEMI, no. (%) 814 (60.6) 780 (60.0) 633 (61.6) 0.736 0.633
Coronary angiography within 24 h 425 (52.2) 416 (53.3) 358 (56.5) 0.690 0.111
Coronary angiography 2472 h 191 (23.4) 219 (28.1) 183 (28.9) 0.040 0.022
PCI 491 (60.3) 479 (61.4) 392 (62.0) 0.693 0.570
Admission to ICU 220 (16.4) 225 (17.3) 177 (17.2) 0.53 0.589
Admission to CCU 820 (61.1) 795 (61.1) 643 (62.5) 0.979 0.459
Intra Aortic Balloon Pump 31 (2.3) 35 (2.7) 17 (1.7) 0.529 0.262
Duration CCU stay, (days) 2.8 § 3.7 2.8 § 3.9 2.8 § 3.5 0.742 0.923
Duration hospital stay, (days) 8 § 8.2 7.5 § 7.7 6.9 § 6.2 0.092 <0.001
Before is defined as the temporal range from January 1 to February 21, 2020. The first wave was from February 22 to May 13, 2020.
The time range after the first wave was fromMay 14 to June 30, 2020.
p1 is for the comparison between before and first wave subgroups. p2 is for the comparison between after and before subgroups.
* : data is available in 58% of the cases.
MI: myocardial infarction. HF: heart failure. COPD: chronic obstructive pulmonary disease. STEMI: ST-segment elevation MI. PCI:
percutaneous coronary intervention. FMC: first medical contact. NSTEMI: non ST-segment elevation MI. ICU: intensive care unit.
CCU: cardiac care unit.
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(Fig. 3).4. Discussion
The key insights of our analysis are:
i. in Emilia-Romagna, one of the regions of the North Italy most
severely hit by the COVID-19 pandemic, the diffusion of SARS-
CoV-2 infection has been associated with a significant reduction
in hospital admissions for MI,
ii. during the first wave of the pandemic, patients with MI admitted
to hospital were younger and with less risk factors and comor-
bidities; they continued to receive gold-standard treatments and
their 30-day mortality, after adjustment for potential confound-
ing factors, was in line with historical values,
iii. the number of MI patients with concomitant SARS-CoV-2 infec-
tion was limited (1.5%, 95%CI 1.1%1.9%), but they were under-
treated, and their prognosis was poor,
iv. concurrently with the spreading of the SARS-CoV-2 infection and
the reduction in hospital admission for MI, a significant increase
in out-of-hospital cardiac deaths was observed.From the beginning of the COVID-19 pandemic, hospitals
observed an alarming reduction in admissions for time-dependent
diseases, including MI [8-12]. Although reproducible across the coun-
tries, this observation left several unmet gaps in knowledge. First,
data was mainly collected in high-volume hub centres, and less infor-
mation was available from spoke hospitals or entire MI network. Sec-
ond, the outcome of the patients admitted for MI during the outbreak
was not systematically reported and their prognosis is still unclear.
Third, no studies clarified the out-of-hospital consequences.
The current investigation aimed to fill these gaps, and its major
strengths are: i) data were extracted from a homogenous hub and
spoke MI network including more than 30 hospitals; ii) the analysis
was not limited to pre-established arbitrary temporal windows, but
the historical series starting from January 2017 was reported; iii) cru-
cial information about management and outcome (30-day-mortality)
of MI patients was available (considering both negative and positive
for SARS-CoV-2 infection); iv) in-hospital data were enriched with
out-of-hospital cardiac death to depict the whole spectrum of the
consequences of the COVID-19 pandemic on the MI network.
We confirmed the significant reduction in hospital admissions for
MI. The numbers started to decrease from February 22, 2020, the day
when the first documented Italian case of SARS-CoV-2 infection was
Fig. 1. Daily number of admissions for MI.
The graph on the left represents the number of daily hospital admissions for MI from January 2017 to June 2020. The orange line is the expected trend (based on seasonality),
whereas the red line is the observed trend. The first six months of the year 2020 are highlighted in the light blue box. The upper portion of the light blue box shows the trend of
cases who resulted positive for SARS-CoV-2 infection. The lower portion shows the trend of daily hospital admissions for MI in the first six months of the 2020. The violet range rep-
resents the national lockdown (from March 9 to May 3, 2020). The dotted black lines the dates associated with significant changes in the trend of daily admission for MI. (For inter-
pretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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two main hypotheses. The first is that the lifestyle changes caused by
pandemic and lock-down (staying home, less stress, less air pollu-
tion) triggered fewer coronary events. The opposite theory suggests
that the fear of contagion and the misinterpretation of the “stay-at-
home” government campaign might have hindered people’s decision
to go to hospital in case of MI symptoms. Although not trying to draw
final conclusions from a debate that has not ended, what evolves
from our data (start of the reduction in hospital admission for MI
before the national lockdown, lack of relationship with local number
of COVID-19 cases and return to pre-pandemic statistics coinciding
with the end of the pandemic’s first wave) is that the second hypoth-
esis may be more plausible.
After looking at the previous studies about the outcome of MI
patients admitted during the pandemic, the results seemed conflict-
ing [9, 12-14]. A large retrospective registry focused on STEMI
patients undergoing primary PCI across European centres suggested
an increase in-hospital mortality [12]. In this registry, the characteris-
tics of MI patients admitted during pandemic were similar to those of
their control cohort [12]. Despite this, the in-hospital outcome was
worse [12]. Similarly, a survey involving Italian cardiac care units
found a higher fatality rate during the pandemic [9]. Our study did
not confirm this finding for the Emilia-Romagna region. MI patients
admitted during the pandemic were, on average, younger and with
fewer cardiovascular risk factors. This finding could be interpreted as
a result of the presence of more striking symptoms at presentation in
younger people coupled with a greater fear of contagion in older and
comorbid patients. After adjustments for potential confounding fac-
tors, we found that 30-day mortality of MI patients admitted during
the pandemic was in line with that of the previous years. This finding
is interesting and noteworthy in several ways. The Regional Authority
for Health and Welfare re-organized the activities of the hospitals
during the pandemic by significantly reducing elective proceduresand surgery activities. However, the networks for the management of
the time-dependent disease, including the MI network, have not
been modified. Although longer follow-up is necessary to confirm
our findings, it seems that a well-established and organized MI net-
work is able to work efficiently also during a pandemic, without sig-
nificant changes in mortality. Unfortunately, the same consideration
cannot be applied to MI patients with confirmed SARS-CoV-2 infec-
tion. They were a limited number of cases (1.5% 95%CI 1.1%1.9%)
and tended to show a late presentation. Fewer invasive procedures
were used (both primary PCI for STEMI patients and invasive strategy
for NSTEMI patients). These features translate into a dramatically
higher 30-day mortality (32% vs. 8% of MI patients negative for SARS-
CoV-2 infection, p<0.001).
As mentioned before, previous studies had identified the trend of
a lower number of admissions due to MI [8-12]. However, the ques-
tion of its out-of-hospital consequences was left unsolved. Analyses
focused on the number of out-of-hospital cardiac arrests highlighted
a significant increase during the first wave of the pandemic [15,16].
Looking at MI hospitalization and out-of-hospital cardiac death at the
same time, we found an opposite trend. While the first decreased
with a nadir in March and April, the second increased with a peak in
the same months. Although we may not demonstrate an indissoluble
association between phenomena, we can suppose that a large part of
these out-of-hospital cardiac death can be the missing MIs not admit-
ted to hospital. We believe that this could be due to media campaigns
around Italy to prevent the spread of the virus, targeting, and influ-
encing, especially older patients with more risk factors and comor-
bidities. Hence, older people perceived that they had a higher risk of
death in case of a SARS-CoV-2 contagion and were thus more reluc-
tant to call emergency services in case of MI symptoms. This attitude
led to a significant increase in out-of-hospital cardiac deaths.
We are aware that our research may have some limitations. First,
the hospital admissions for MI were inferred from ICD-9 codes, which
Table 2






(n = 56) (n = 2808)
Age, years 76.1 § 13 71.5 § 13 0.002
< 65 years, no. (%) 8 (14.3) 834 (29.7) <0.001
6574 years, no. (%) 14 (25) 683 (24.3)
7584 years, no. (%) 20 (35.7) 826 (29.4)
85 years, no. (%) 14 (25) 465 (16.6)
Male sex, no. (%) 36 (64.3) 1859 (66.2) 0.764
Comorbidities, no. (%)
Diabetes 13 (23.2) 617 (22) 0.824
Hypertension 23 (41.1) 1187 (42.3) 0.857
Hyperlipidaemia 19 (33.9) 1304 (46.4) 0.063
Prior MI 9 (16.1) 432 (15.4) 0.888
History of HF 17 (30.4) 528 (18.8) 0.029
Peripheral artery disease 4 (7.1) 124 (4.4) 0.328
Cerebrovascular disease 5 (8.9) 204 (7.3) 0.636
COPD 3 (5.4) 114 (4.1) 0.627
Chronic kidney disease 6 (10.7) 274 (9.8) 0.811
History of cancer 0 (0) 20 (0.7) 0.526
Charlson Index >2 13 (23.2) 443 (15.8) 0.132
Hospitalization
STEMI, no. (%) 26 (46.4) 1102 (39.2) 0.276
Anterior location STEMI 13 (50.0) 564 (51.2) 0.905
Inferior location STEMI 7 (26.9) 465 (42.2) 0.119
Coronary angiography 20 (76.9) 1035 (94.0) 0.003
Primary PCI 17 (65.3) 895 (81.2) <0.001
FMC-balloon time, minutes * 95§55 87§45 0.373
NSTEMI, no. (%) 30 (53.6) 1706 (60.8) 0.276
Coronary angiography within 24 h 7 (23.3) 947 (55.5) <0.001
Coronary angiography within
2472 h
9 (30.0) 481 (28.2) 0.738
PCI 15 (50.0) 1054 (61.8) 0.260
The group of MI patients negative for SARS-CoV-2 infection were admitted from
February 2020 to June 2020.
* : data is available in 61% of the cases.
MI: myocardial infarction. HF: heart failure. COPD: chronic obstructive pulmo-
nary disease. STEMI: ST-segment elevation MI. PCI: percutaneous coronary
intervention. FMC: first medical contact. NSTEMI: non ST-segment elevation MI.
Fig. 2. Thirty-day mortality of patients hospitalized for MI.
The upper portion of the Figure shows the monthly 30-day mortality of patients
admitted to hospital for MI from January 2017 to June 2020. The lower part of the
Figure shows the ratios between observed and expected 30-day deaths of MI patients.
The expected number was computed based on data from the years 20172019 and
after adjustment for confounding factors.
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applied in several previous analyses and periodic audits verified
with source data the consistency of the information [1-4]. Second,
some MI cases with concomitant SARS-CoV-2 infection could have
gone undiagnosed, especially in the last week of February and in
the first week of March. However, this number should be small
because screening for SARS-CoV-2 was systematically applied in
hospitalized subjects and the risk of bias on our findings should be
considered limited. Third, the cause of out-of-hospital deaths was
based on that reported in the death certificates. Although guide-
lines for the discrimination of the primary cause of death are well-
established and applied in our region, we may not exclude some
bias. This may have led us to overestimate cardiac causes of death
or underestimate cases with asymptomatic concomitant SARS-
CoV-2 infection. Nevertheless, the same methodology was applied
over the years (from 2017 to 2020), therefore the risk of bias or
misinterpretation should be minimal. Fourth, the trend of out-of-
hospital cardiac arrest would have further enriched our findings
and allowed a link between the reduction in MI admissions and
the increase in out-of-hospital cardiac death. Unfortunately, this
data is traced only in some areas of the region [17]. Of note, avail-
able evidence suggested a trend for the increase of the activations
of the emergency service for out-of-hospital cardiac arrests [17].
Finally, it should be noted that the unequivocal proof that out-of-
hospital death was cardiac (and not suspected cardiac) would
require an autoptic evidence. Likewise, autoptic evidence and the
demonstration that hospital admission of these subjects would
have saved their life, would be necessary to prove that theincreased out-of-hospital cardiac death was consequence of “miss-
ing MIs”. Obviously, this is not feasible and goes beyond the scope
of the present analysis.
In Emilia-Romagna, the first wave of the COVID-19 pandemic has
been associated with a significant reduction in hospital admissions
for MI. The patients admitted to hospitals continued to receive stan-
dard-of-care treatment without changes in 30-day mortality, except
for those with concomitant SARS-CoV-2 infection who were under-
treated and with a 5-time increased risk of death. Together with
the reduction in MI hospital admissions, a significant increase in the
out-of-hospital cardiac deaths was observed.Author Contributions
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